COVID-19 Impact on Global Psoriatic Arthritis (PsA) Treatment Market Size, Status and Forecast 2020-2026

July 2020 | 93 pages | ID: CC51F6495BFFEN
QYResearch

Abstracts

This report focuses on the global Psoriatic Arthritis (PsA) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Psoriatic Arthritis (PsA) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Johnson & Johnson
• AbbVie
• Novartis
• UCB
• Roche
• Bristol-Myers Squibb
• Eli Lilly
• Amgen
• AstraZeneca
• Celgene

Market segment by Type, the product can be split into

• Nonsteriodal Anti-inflammatory Drugs
• Disease Modifying Antirheumatic Drugs
• Biologics

Market segment by Application, split into

• Hospitals
• Clinics
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Psoriatic Arthritis (PsA) Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Psoriatic Arthritis (PsA) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Psoriatic Arthritis (PsA) Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Psoriatic Arthritis (PsA) Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Nonsteriodal Anti-inflammatory Drugs
  1.4.3 Disease Modifying Antirheumatic Drugs
  1.4.4 Biologics
1.5 Market by Application
  1.5.1 Global Psoriatic Arthritis (PsA) Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Psoriatic Arthritis (PsA) Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Psoriatic Arthritis (PsA) Treatment Industry
    1.6.1.1 Psoriatic Arthritis (PsA) Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Psoriatic Arthritis (PsA) Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Psoriatic Arthritis (PsA) Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Psoriatic Arthritis (PsA) Treatment Market Perspective (2015-2026)
2.2 Psoriatic Arthritis (PsA) Treatment Growth Trends by Regions
  2.2.1 Psoriatic Arthritis (PsA) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Psoriatic Arthritis (PsA) Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Psoriatic Arthritis (PsA) Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Psoriatic Arthritis (PsA) Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Market Size
  3.1.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue (2015-2020)
  3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Psoriatic Arthritis (PsA) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio
  3.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis (PsA) Treatment Revenue in 2019
3.3 Psoriatic Arthritis (PsA) Treatment Key Players Head office and Area Served
3.4 Key Players Psoriatic Arthritis (PsA) Treatment Product Solution and Service
3.5 Date of Enter into Psoriatic Arthritis (PsA) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2021-2026)

5 PSORIATIC ARTHRITIS (PSA) TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)
5.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Psoriatic Arthritis (PsA) Treatment Market Size (2015-2020)
6.2 Psoriatic Arthritis (PsA) Treatment Key Players in North America (2019-2020)
6.3 North America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020)
6.4 North America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size (2015-2020)
7.2 Psoriatic Arthritis (PsA) Treatment Key Players in Europe (2019-2020)
7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020)
7.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Psoriatic Arthritis (PsA) Treatment Market Size (2015-2020)
8.2 Psoriatic Arthritis (PsA) Treatment Key Players in China (2019-2020)
8.3 China Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020)
8.4 China Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Psoriatic Arthritis (PsA) Treatment Market Size (2015-2020)
9.2 Psoriatic Arthritis (PsA) Treatment Key Players in Japan (2019-2020)
9.3 Japan Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020)
9.4 Japan Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size (2015-2020)
10.2 Psoriatic Arthritis (PsA) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Psoriatic Arthritis (PsA) Treatment Market Size (2015-2020)
11.2 Psoriatic Arthritis (PsA) Treatment Key Players in India (2019-2020)
11.3 India Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020)
11.4 India Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Psoriatic Arthritis (PsA) Treatment Market Size (2015-2020)
12.2 Psoriatic Arthritis (PsA) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Introduction
  13.1.4 Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Johnson & Johnson
  13.2.1 Johnson & Johnson Company Details
  13.2.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Introduction
  13.2.4 Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
  13.2.5 Johnson & Johnson Recent Development
13.3 AbbVie
  13.3.1 AbbVie Company Details
  13.3.2 AbbVie Business Overview and Its Total Revenue
  13.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Introduction
  13.3.4 AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
  13.3.5 AbbVie Recent Development
13.4 Novartis
  13.4.1 Novartis Company Details
  13.4.2 Novartis Business Overview and Its Total Revenue
  13.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Introduction
  13.4.4 Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
  13.4.5 Novartis Recent Development
13.5 UCB
  13.5.1 UCB Company Details
  13.5.2 UCB Business Overview and Its Total Revenue
  13.5.3 UCB Psoriatic Arthritis (PsA) Treatment Introduction
  13.5.4 UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
  13.5.5 UCB Recent Development
13.6 Roche
  13.6.1 Roche Company Details
  13.6.2 Roche Business Overview and Its Total Revenue
  13.6.3 Roche Psoriatic Arthritis (PsA) Treatment Introduction
  13.6.4 Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
  13.6.5 Roche Recent Development
13.7 Bristol-Myers Squibb
  13.7.1 Bristol-Myers Squibb Company Details
  13.7.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Introduction
  13.7.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
  13.7.5 Bristol-Myers Squibb Recent Development
13.8 Eli Lilly
  13.8.1 Eli Lilly Company Details
  13.8.2 Eli Lilly Business Overview and Its Total Revenue
  13.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Introduction
  13.8.4 Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
  13.8.5 Eli Lilly Recent Development
13.9 Amgen
  13.9.1 Amgen Company Details
  13.9.2 Amgen Business Overview and Its Total Revenue
  13.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Introduction
  13.9.4 Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
  13.9.5 Amgen Recent Development
13.10 AstraZeneca
  13.10.1 AstraZeneca Company Details
  13.10.2 AstraZeneca Business Overview and Its Total Revenue
  13.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Introduction
  13.10.4 AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
  13.10.5 AstraZeneca Recent Development
13.11 Celgene
  10.11.1 Celgene Company Details
  10.11.2 Celgene Business Overview and Its Total Revenue
  10.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Introduction
  10.11.4 Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
  10.11.5 Celgene Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Psoriatic Arthritis (PsA) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Psoriatic Arthritis (PsA) Treatment Revenue
Table 3. Ranking of Global Top Psoriatic Arthritis (PsA) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Nonsteriodal Anti-inflammatory Drugs
Table 6. Key Players of Disease Modifying Antirheumatic Drugs
Table 7. Key Players of Biologics
Table 8. COVID-19 Impact Global Market: (Four Psoriatic Arthritis (PsA) Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Psoriatic Arthritis (PsA) Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Psoriatic Arthritis (PsA) Treatment Players to Combat Covid-19 Impact
Table 13. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Psoriatic Arthritis (PsA) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Psoriatic Arthritis (PsA) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Psoriatic Arthritis (PsA) Treatment Market Share by Regions (2015-2020)
Table 17. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Psoriatic Arthritis (PsA) Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Psoriatic Arthritis (PsA) Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Psoriatic Arthritis (PsA) Treatment Players
Table 24. Global Psoriatic Arthritis (PsA) Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Psoriatic Arthritis (PsA) Treatment Market Share by Players (2015-2020)
Table 26. Global Top Psoriatic Arthritis (PsA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2019)
Table 27. Global Psoriatic Arthritis (PsA) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Psoriatic Arthritis (PsA) Treatment Product Solution and Service
Table 30. Date of Enter into Psoriatic Arthritis (PsA) Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Psoriatic Arthritis (PsA) Treatment Market Size Share by Type (2015-2020)
Table 34. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Psoriatic Arthritis (PsA) Treatment Market Size Share by Application (2015-2020)
Table 36. Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Psoriatic Arthritis (PsA) Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Psoriatic Arthritis (PsA) Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Psoriatic Arthritis (PsA) Treatment Market Share (2019-2020)
Table 40. North America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Psoriatic Arthritis (PsA) Treatment Market Share by Type (2015-2020)
Table 42. North America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Psoriatic Arthritis (PsA) Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Psoriatic Arthritis (PsA) Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Psoriatic Arthritis (PsA) Treatment Market Share (2019-2020)
Table 46. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Psoriatic Arthritis (PsA) Treatment Market Share by Type (2015-2020)
Table 48. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Psoriatic Arthritis (PsA) Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Psoriatic Arthritis (PsA) Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Psoriatic Arthritis (PsA) Treatment Market Share (2019-2020)
Table 52. China Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Psoriatic Arthritis (PsA) Treatment Market Share by Type (2015-2020)
Table 54. China Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Psoriatic Arthritis (PsA) Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Psoriatic Arthritis (PsA) Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Psoriatic Arthritis (PsA) Treatment Market Share (2019-2020)
Table 58. Japan Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Psoriatic Arthritis (PsA) Treatment Market Share by Type (2015-2020)
Table 60. Japan Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Psoriatic Arthritis (PsA) Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Psoriatic Arthritis (PsA) Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Psoriatic Arthritis (PsA) Treatment Market Share (2019-2020)
Table 64. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Psoriatic Arthritis (PsA) Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Psoriatic Arthritis (PsA) Treatment Market Share (2019-2020)
Table 70. India Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Psoriatic Arthritis (PsA) Treatment Market Share by Type (2015-2020)
Table 72. India Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Psoriatic Arthritis (PsA) Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Psoriatic Arthritis (PsA) Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Psoriatic Arthritis (PsA) Treatment Market Share (2019-2020)
Table 76. Central & South America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Psoriatic Arthritis (PsA) Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Psoriatic Arthritis (PsA) Treatment Market Share by Application (2015-2020)
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Johnson & Johnson Company Details
Table 86. Johnson & Johnson Business Overview
Table 87. Johnson & Johnson Product
Table 88. Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020) (Million US$)
Table 89. Johnson & Johnson Recent Development
Table 90. AbbVie Company Details
Table 91. AbbVie Business Overview
Table 92. AbbVie Product
Table 93. AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020) (Million US$)
Table 94. AbbVie Recent Development
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Product
Table 98. Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020) (Million US$)
Table 99. Novartis Recent Development
Table 100. UCB Company Details
Table 101. UCB Business Overview
Table 102. UCB Product
Table 103. UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020) (Million US$)
Table 104. UCB Recent Development
Table 105. Roche Company Details
Table 106. Roche Business Overview
Table 107. Roche Product
Table 108. Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020) (Million US$)
Table 109. Roche Recent Development
Table 110. Bristol-Myers Squibb Company Details
Table 111. Bristol-Myers Squibb Business Overview
Table 112. Bristol-Myers Squibb Product
Table 113. Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020) (Million US$)
Table 114. Bristol-Myers Squibb Recent Development
Table 115. Eli Lilly Business Overview
Table 116. Eli Lilly Product
Table 117. Eli Lilly Company Details
Table 118. Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020) (Million US$)
Table 119. Eli Lilly Recent Development
Table 120. Amgen Company Details
Table 121. Amgen Business Overview
Table 122. Amgen Product
Table 123. Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020) (Million US$)
Table 124. Amgen Recent Development
Table 125. AstraZeneca Company Details
Table 126. AstraZeneca Business Overview
Table 127. AstraZeneca Product
Table 128. AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020) (Million US$)
Table 129. AstraZeneca Recent Development
Table 130. Celgene Company Details
Table 131. Celgene Business Overview
Table 132. Celgene Product
Table 133. Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2015-2020) (Million US$)
Table 134. Celgene Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Psoriatic Arthritis (PsA) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Nonsteriodal Anti-inflammatory Drugs Features
Figure 3. Disease Modifying Antirheumatic Drugs Features
Figure 4. Biologics Features
Figure 5. Global Psoriatic Arthritis (PsA) Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Psoriatic Arthritis (PsA) Treatment Report Years Considered
Figure 10. Global Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Psoriatic Arthritis (PsA) Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Psoriatic Arthritis (PsA) Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Psoriatic Arthritis (PsA) Treatment Market Share by Players in 2019
Figure 15. Global Top Psoriatic Arthritis (PsA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Psoriatic Arthritis (PsA) Treatment Revenue in 2019
Figure 17. North America Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Pfizer Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
Figure 26. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Johnson & Johnson Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
Figure 28. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. AbbVie Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
Figure 32. UCB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. UCB Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
Figure 34. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Roche Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
Figure 36. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bristol-Myers Squibb Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
Figure 38. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Eli Lilly Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
Figure 40. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Amgen Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
Figure 42. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. AstraZeneca Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
Figure 44. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Celgene Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed